Lei-Lei Chen

Lei-Lei Chen

Auto-generated profile, based on publicly available information

Lei-Lei Chen

Molecular and Cell Biology Lab, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Shanghai Medical College, Fudan University, Shanghai, China.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in Science Advances
Verified
Journal Article
Closed access
YCYu-Jia Chen
Yu-Jia Chen
GLGuan-Nan Li
Guan-Nan Li
XLXian-Jing Li
Xian-Jing Li
LWLin-Xing Wei
Lin-Xing Wei
MFMin-Jie Fu
Min-Jie Fu
LCLei-Lei Chen
Lei-Lei Chen
Immune-responsive gene 1 (IRG1) encodes aconitate decarboxylase (ACOD1) that catalyzes the production of itaconic acids (ITAs). The anti-inflammatory function of IRG1/ITA has been established in multiple pathogen models, but very little is known in cancer. Here, we show that IRG1 is expressed in tumor-associated macrophages (TAMs) in both human and mouse tumors. Mechanistically, tumor cells induce Irg1 expression in macrophages by activating NF-κB pathway, and ITA produced by ACOD1 inhibits TET DNA dioxygenases to dampen the expression of inflammatory genes and the infiltration of CD8 + T cells into tumor sites. Deletion of Irg1 in mice suppresses the growth of multiple tumor types and enhances the efficacy of anti–PD-(L)1 immunotherapy. Our study provides a proof of concept that ACOD1 is a potential target for immune-oncology drugs and IRG1 -deficient macrophages represent a potent cell therapy strategy for cancer treatment even in pancreatic tumors that are resistant to T cell–based immunotherapy.

18 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LCLei-Lei Chen
Lei-Lei Chen
MSMatthew D. Smith
Matthew D. Smith
LLLei Lv
Lei Lv
TNTadashi Nakagawa
Tadashi Nakagawa
ZLZhijun Li
Zhijun Li
YXYanping Xu
Yanping Xu
TET2 DNA dioxygenase is frequently mutated in human hematopoietic malignancies and functionally inactivated in many solid tumors through a nonmutational mechanism. We recently found that TET2 mediates the interferon-JAK-STAT pathway to stimulate chemokine expression and tumor infiltration of lymphocytes (TILs). TET2 is monoubiquitylated at K1299, which promotes its activity. Here, we report that USP15 is a TET2 deubiquitinase and inhibitor. USP15 catalyzes the removal of K1299-linked monoubiquitin and negatively regulates TET2 activity. Gene expression profiling demonstrates that TET2 and USP15 oppositely regulate genes involved in multiple inflammatory pathways, and TET2 is a major target of USP15 function. Deletion of Usp15 in melanoma stimulates chemokine expression and TILs in a TET2-dependent manner, leading to increased response to immunotherapy and extended life span of tumor-bearing mice. These results reveal a previously unknown regulator of TET2 activity and suggest USP15 as a potential therapeutic target for immunotherapy of solid tumors.

28 May 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YXYun Xue
Yun Xue
YCYuting Chen
Yuting Chen
SSSijia Sun
Sijia Sun
XTXinyuan Tong
Xinyuan Tong
YCYujia Chen
Yujia Chen
HJHongbin Ji
Hongbin Ji
Phenotypic plasticity is a rising cancer hallmark, and lung adeno-to-squamous transition (AST) triggered by LKB1 inactivation is significantly associated with drug resistance. Mechanistic insights into AST are urgently needed to identify therapeutic vulnerability in LKB1-deficient lung cancer. Here, we find that ten-eleven translocation (TET)–mediated DNA demethylation is elevated during AST in KrasLSL-G12D/+; Lkb1L/L (KL) mice, and knockout of individual Tet genes reveals that Tet2 is required for squamous transition. TET2 promotes neutrophil infiltration through STAT3-mediated CXCL5 expression. Targeting the STAT3–CXCL5 nexus effectively inhibits squamous transition through reducing neutrophil infiltration. Interestingly, tumor-infiltrating neutrophils are laden with triglycerides and can transfer the lipid to tumor cells to promote cell proliferation and squamous transition. Pharmacological inhibition of macropinocytosis dramatically inhibits neutrophil-to–cancer cell lipid transfer and blocks squamous transition. These data uncover an epigenetic mechanism orchestrating phenotypic plasticity through regulating immune microenvironment and metabolic communication, and identify therapeutic strategies to inhibit AST.

18 February 2025 in Protein & Cell
Verified
Journal Article
Open access
SLShuang Liu
Shuang Liu
LWLin-Xing Wei
Lin-Xing Wei
QYQian Yu
Qian Yu
ZGZhi-Wei Guo
Zhi-Wei Guo
CZChangyou Zhan
Changyou Zhan
DYDan Ye
Dan Ye

14 July 2026 in Nature Metabolism
Verified
Journal Article
Closed access
LCLei-Lei Chen
Lei-Lei Chen
DYDan Ye
Dan Ye